Shuttle Pharmaceuticals Holdings (SHPH) Retained Earnings (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Retained Earnings history runs 6 years deep, the most recent figure standing at $51.8 million for Q1 2026.

• On a quarterly basis, Retained Earnings rose 26.6% year-over-year to $51.8 million in Q1 2026; TTM through Mar 2026 was $51.8 million, a 26.6% increase from a year earlier, with the FY2025 full-year figure at -$46.3 million, down 231.21% from the prior year.
• Retained Earnings grew to $51.8 million in Q1 2026 per SHPH's latest filing, from -$46.3 million in the prior quarter.
• Across five years, Retained Earnings topped out at $51.8 million in Q1 2026 and bottomed at -$46.3 million in Q4 2025.
• The 5-year median for Retained Earnings is $29.5 million (2023), against an average of $14.5 million.
• Across the five-year window, Retained Earnings plunged 256.17% in 2022 and soared 461.03% in 2023, its largest moves.
• Year by year, Retained Earnings stood at -$18.8 million in 2022, then jumped by 256.52% to $29.5 million in 2023, then rose by 19.66% to $35.3 million in 2024, then slumped by 231.21% to -$46.3 million in 2025, then surged by 211.88% to $51.8 million in 2026.
• Per Business Quant, the three latest SHPH Retained Earnings figures stand at $51.8 million (Q1 2026), -$46.3 million (Q4 2025), and $45.1 million (Q3 2025).